CO5070598A1 - ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF A UNIQUE ANTI-CONCEPTIVE AGENT THAT IS A STEROID COMPOSITE THAT COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES - Google Patents

ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF A UNIQUE ANTI-CONCEPTIVE AGENT THAT IS A STEROID COMPOSITE THAT COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES

Info

Publication number
CO5070598A1
CO5070598A1 CO99014138A CO99014138A CO5070598A1 CO 5070598 A1 CO5070598 A1 CO 5070598A1 CO 99014138 A CO99014138 A CO 99014138A CO 99014138 A CO99014138 A CO 99014138A CO 5070598 A1 CO5070598 A1 CO 5070598A1
Authority
CO
Colombia
Prior art keywords
conceptive
progestagenic
kit
combines
activities
Prior art date
Application number
CO99014138A
Other languages
Spanish (es)
Inventor
Kloosterboer Helenius Jan
Hermanus Johana Godefridus
Antonius Maria Johannes
Michiel Verbost Pieter
Tijmen Herman Jan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5070598A1 publication Critical patent/CO5070598A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Un kit anticonceptivo que comprende medios para la administración de un agente anticonceptivo durante una secuencia continua de un número de días, opcionalmente seguido por un intervalo de placebos o libre de píldora, CARACTERIZADO porque el agente anticonceptivo único es un compuesto esteroide que tiene un perfil de actividad que combina inherentemente las actividades progestagénica y estrogénica.A contraceptive kit comprising means for the administration of a contraceptive agent during a continuous sequence of a number of days, optionally followed by a range of placebos or pill-free, CHARACTERIZED because the sole contraceptive agent is a steroid compound that has a profile of activity that inherently combines progestagenic and estrogenic activities.

CO99014138A 1998-03-09 1999-03-08 ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF A UNIQUE ANTI-CONCEPTIVE AGENT THAT IS A STEROID COMPOSITE THAT COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES CO5070598A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09

Publications (1)

Publication Number Publication Date
CO5070598A1 true CO5070598A1 (en) 2001-08-28

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99014138A CO5070598A1 (en) 1998-03-09 1999-03-08 ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF A UNIQUE ANTI-CONCEPTIVE AGENT THAT IS A STEROID COMPOSITE THAT COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES

Country Status (20)

Country Link
EP (1) EP1061928A2 (en)
JP (1) JP2002506014A (en)
KR (1) KR20010041698A (en)
CN (1) CN1292702A (en)
AR (1) AR018313A1 (en)
AU (1) AU756882B2 (en)
BR (1) BR9908605A (en)
CA (1) CA2319765A1 (en)
CO (1) CO5070598A1 (en)
HU (1) HUP0101007A3 (en)
ID (1) ID25621A (en)
IL (1) IL137541A0 (en)
NO (1) NO20004492D0 (en)
NZ (1) NZ506115A (en)
PE (1) PE20000330A1 (en)
PL (1) PL343428A1 (en)
RU (1) RU2225714C2 (en)
TR (1) TR200002593T2 (en)
WO (1) WO1999045886A2 (en)
ZA (1) ZA991851B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
TR200200575T2 (en) * 1999-09-06 2002-06-21 Akzo Nobel N. V. Non-aromatic estrogenic steroids with a hydrocarbon substituent at position 11.
BR0112791A (en) 2000-07-28 2003-06-24 Akzo Nobel Nv 16alpha-substituted steroidal compound, use thereof, treatment methods for selective activation of alpha subtype estrogen receptors, and for hormone replacement therapy or contraception, and, pharmaceutical composition
JP2005519964A (en) * 2002-03-11 2005-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Sulfatase-inhibiting progestogen-only contraceptive regimen
US20030225048A1 (en) * 2002-03-11 2003-12-04 Caubel Patrick Michel Sulfatase inhibiting continuous progestogen contraceptive regimens
UA89964C2 (en) 2004-09-08 2010-03-25 Н.В. Органон 15beta-substituted steroids having selective estrogenic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (en) * 1977-02-10 1978-08-14 Akzo Nv PROCESS FOR PREPARING NEW STEROIDS FROM THE OESTRAINE SERIES.
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
RU2225714C2 (en) 2004-03-20
NO20004492L (en) 2000-09-08
ID25621A (en) 2000-10-19
HUP0101007A3 (en) 2002-02-28
JP2002506014A (en) 2002-02-26
HUP0101007A2 (en) 2001-12-28
NO20004492D0 (en) 2000-09-08
KR20010041698A (en) 2001-05-25
BR9908605A (en) 2001-04-24
WO1999045886A3 (en) 1999-12-02
ZA991851B (en) 1999-09-22
NZ506115A (en) 2003-07-25
AU756882B2 (en) 2003-01-23
EP1061928A2 (en) 2000-12-27
TR200002593T2 (en) 2000-12-21
AU3143799A (en) 1999-09-27
WO1999045886A2 (en) 1999-09-16
CN1292702A (en) 2001-04-25
IL137541A0 (en) 2001-07-24
PE20000330A1 (en) 2000-05-16
AR018313A1 (en) 2001-11-14
CA2319765A1 (en) 1999-09-16
PL343428A1 (en) 2001-08-13

Similar Documents

Publication Publication Date Title
ES2179273T3 (en) N-BENCIL-2-PHENYLINDOLS AS ESTROGENIC AGENTS.
HN1999000124A (en) SUBSTITUTED PYRAZOLE DERIVATIVES.
ES2156150T3 (en) THERAPEUTIC COMBINATION CONTAINING INTERFERED.
ES2174920T3 (en) COMBINATION PRODUCT FOR CONTRACEPTION CONTAINING PROGESTERONE ANTAGONIST AGENTS AND A GESTAGEN AGENT.
DE69434491D1 (en) SKIN PATIENT CONTAINS TESTOSTERONE AND, IF ANY, ESTROGEN
DK1011682T3 (en) Hormonal contraceptives
PT797439E (en) USING PRAMIPEXOTE AS A NEUROPROTECTOR AGENT
ES2190472T3 (en) TRANSDERMIC PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, ONLY OR IN COMBINATION WITH A STROGEN.
ECSP034455A (en) DOSAGE FORM OF PHARMACO ACTIVATED BY HYDROGEL
AR001982A1 (en) PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
ES2194989T3 (en) COMPOSITION ADMINSTRATED BY ORAL ROUTE, THAT INCLUDES AN OXLUDENS ZONULA TOXIN AND AN AGENT THAT HAS A BIOLOGICAL ACTIVITY, AND ITS USE.
CR7610A (en) USE OF THIO-OXINDOL DERIVATIVES IN THE TREATMENT OF CONDITIONS MADE WITH HORMONE
NO986104L (en) Progesterone-anti-progesterone regimens
AR019198A1 (en) IMPLANTABLE SYSTEM FOR THE SUBCUTANEOUS OR LOCAL ADMINISTRATION OF AN ADROGEN AND IMPLANT.
ES2179945T3 (en) TETRALINE COMPOUNDS WITH RESISTANCE ACTIVITY TO MULTIPLE DRUGS.
AR015933A1 (en) ENAMEL FOR ONE WITH ANTIPSORIASIC ACTIVITY AND PROCEDURE FOR PREPARATION
AR040130A1 (en) ETONOGESTREL ESTERES, ITS USE AS ANTICOPCEPTIVE AND FOR THE TREATMENT OF GYNECOLOGICAL DISORDERS
BR0107667A (en) Crystal linezolid compound which is pharmaceutically useful as an antibacterial agent and method of preparing it
AR012504A1 (en) USE OF TETRAHYDROPYRIDINE DERIVATIVES, FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES WHICH CAUSE A DEMELINATION.
DK0998287T3 (en) Use of levobupivacaine
ES2133412T3 (en) 2 ', 5'-OLIGOADENYLATE-2', 3'-CYCLOPHOSPHATES AND 2 ', 5'-OLIGOADENYLATES WITH ACTIVITY ON THE PAPILOMA VIRUS.
ES2180774T3 (en) THE USE OF GLYCERYL TRIACETATE FOR THE TREATMENT OF ONYCOMYCOSIS.
CO5070598A1 (en) ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF A UNIQUE ANTI-CONCEPTIVE AGENT THAT IS A STEROID COMPOSITE THAT COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES
TR200201071T2 (en) Emphysema treatment using Rar selective retinoid antagonists
AR028448A1 (en) FORMULATIONS CONTAINING A GLUCOCORTICOID DRUG FOR THE TREATMENT OF BRONCOPULMONARY DISEASES